Skip to content
Inicio
Login
Descubre más: busca en todos nuestros recursos
All Fields
Title
Author
Subject
Find
Advanced
🎤
1620O Phase I study of TK216,...
Text this
Text this:
1620O Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma.
Number:
Provider:
Select your carrier
Cricket
T Mobile
Verizon
Virgin Mobile